While PERK-mRNA levels remained constant in all treatment conditions, we found that combining DOX with 4μ8C reduced ATF4 and CHOP-levels compared to untreated HCC levels (Figure 4E and F). This evidence concerns the gene DDIT3 and hepatocellular carcinoma.